Tuberculosis
Weill Cornell develops engineered mycobacteria with kill switches for safer TB vaccine trials, a breakthrough in tuberculosis research
| 3 min read
Shared geographic origin between TB strain and human host could amplify risk for infection
| 5+ min read
CRISPR-based platform simplifies and shortens diagnoses of nontuberculosis mycobacteria from 6 months to 2 hours
| 2 min read
Novel tuberculosis vaccine demonstrated strong immune response in mice
| 3 min read
To date, efforts to develop new treatments for TB have been unsuccessful, with current treatments having been used for over 50 years
| 2 min read
Detailed genetic road map will guide research into TB treatments, vaccines
| 4 min read
New guideline emphasizes treatment of drug-resistant tuberculosis with all-oral regimens and provides recommendations for treatment of all contacts to MDR-TB patients
| 3 min read
Scientists have uncovered that the tuberculosis bacterium hijacks platelets from the body's blood clotting system to weaken our immune systems
| 2 min read
